Gastric cancer: Clinical Practice Guidelines in oncology™

Jaffer Ajani, Tanios Bekaii-Saab, Thomas A. D'Amico, Charles Fuchs, Michael K. Gibson, Melvyn Goldberg, James A. Hayman, David H. Ilson, Milind Javle, Scott Kelley, Robert C. Kurtz, Gershon Yehuda Locker, Neal J. Meropol, Bruce D. Minsky, Mark B. Orringer, Raymond U. Osarogiagbon, James A. Posey, Jack Roth, Aaron R. Sasson, Stephen G. SwisherDouglas E. Wood, Yun Yen

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.

Original languageEnglish
Pages (from-to)350-366
Number of pages17
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume4
Issue number4
Publication statusPublished - Apr 2006
Externally publishedYes

Fingerprint

Practice Guidelines
Stomach Neoplasms
Stomach
Histology
Carcinoma
Active Immunotherapy
Endosonography
Adjuvant Radiotherapy
Angiogenesis Inhibitors
Neoplasm Staging
Combination Drug Therapy
Genetic Therapy
Laparoscopy
Dissection
Lymph Nodes
Guidelines
Incidence
Therapeutics

Keywords

  • Chemoradiation
  • Chemotherapy
  • Combined modality therapy
  • Gastric carcinoma
  • NCCN Clinical Practice Guidelines
  • Resection
  • Surgery

ASJC Scopus subject areas

  • Oncology

Cite this

Ajani, J., Bekaii-Saab, T., D'Amico, T. A., Fuchs, C., Gibson, M. K., Goldberg, M., ... Yen, Y. (2006). Gastric cancer: Clinical Practice Guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 4(4), 350-366.

Gastric cancer : Clinical Practice Guidelines in oncology™. / Ajani, Jaffer; Bekaii-Saab, Tanios; D'Amico, Thomas A.; Fuchs, Charles; Gibson, Michael K.; Goldberg, Melvyn; Hayman, James A.; Ilson, David H.; Javle, Milind; Kelley, Scott; Kurtz, Robert C.; Locker, Gershon Yehuda; Meropol, Neal J.; Minsky, Bruce D.; Orringer, Mark B.; Osarogiagbon, Raymond U.; Posey, James A.; Roth, Jack; Sasson, Aaron R.; Swisher, Stephen G.; Wood, Douglas E.; Yen, Yun.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 4, No. 4, 04.2006, p. 350-366.

Research output: Contribution to journalArticle

Ajani, J, Bekaii-Saab, T, D'Amico, TA, Fuchs, C, Gibson, MK, Goldberg, M, Hayman, JA, Ilson, DH, Javle, M, Kelley, S, Kurtz, RC, Locker, GY, Meropol, NJ, Minsky, BD, Orringer, MB, Osarogiagbon, RU, Posey, JA, Roth, J, Sasson, AR, Swisher, SG, Wood, DE & Yen, Y 2006, 'Gastric cancer: Clinical Practice Guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 4, pp. 350-366.
Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M et al. Gastric cancer: Clinical Practice Guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2006 Apr;4(4):350-366.
Ajani, Jaffer ; Bekaii-Saab, Tanios ; D'Amico, Thomas A. ; Fuchs, Charles ; Gibson, Michael K. ; Goldberg, Melvyn ; Hayman, James A. ; Ilson, David H. ; Javle, Milind ; Kelley, Scott ; Kurtz, Robert C. ; Locker, Gershon Yehuda ; Meropol, Neal J. ; Minsky, Bruce D. ; Orringer, Mark B. ; Osarogiagbon, Raymond U. ; Posey, James A. ; Roth, Jack ; Sasson, Aaron R. ; Swisher, Stephen G. ; Wood, Douglas E. ; Yen, Yun. / Gastric cancer : Clinical Practice Guidelines in oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2006 ; Vol. 4, No. 4. pp. 350-366.
@article{8f664f4d569e42e0983da98c36e2fbd9,
title = "Gastric cancer: Clinical Practice Guidelines in oncology™",
abstract = "Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.",
keywords = "Chemoradiation, Chemotherapy, Combined modality therapy, Gastric carcinoma, NCCN Clinical Practice Guidelines, Resection, Surgery",
author = "Jaffer Ajani and Tanios Bekaii-Saab and D'Amico, {Thomas A.} and Charles Fuchs and Gibson, {Michael K.} and Melvyn Goldberg and Hayman, {James A.} and Ilson, {David H.} and Milind Javle and Scott Kelley and Kurtz, {Robert C.} and Locker, {Gershon Yehuda} and Meropol, {Neal J.} and Minsky, {Bruce D.} and Orringer, {Mark B.} and Osarogiagbon, {Raymond U.} and Posey, {James A.} and Jack Roth and Sasson, {Aaron R.} and Swisher, {Stephen G.} and Wood, {Douglas E.} and Yun Yen",
year = "2006",
month = "4",
language = "English",
volume = "4",
pages = "350--366",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "4",

}

TY - JOUR

T1 - Gastric cancer

T2 - Clinical Practice Guidelines in oncology™

AU - Ajani, Jaffer

AU - Bekaii-Saab, Tanios

AU - D'Amico, Thomas A.

AU - Fuchs, Charles

AU - Gibson, Michael K.

AU - Goldberg, Melvyn

AU - Hayman, James A.

AU - Ilson, David H.

AU - Javle, Milind

AU - Kelley, Scott

AU - Kurtz, Robert C.

AU - Locker, Gershon Yehuda

AU - Meropol, Neal J.

AU - Minsky, Bruce D.

AU - Orringer, Mark B.

AU - Osarogiagbon, Raymond U.

AU - Posey, James A.

AU - Roth, Jack

AU - Sasson, Aaron R.

AU - Swisher, Stephen G.

AU - Wood, Douglas E.

AU - Yen, Yun

PY - 2006/4

Y1 - 2006/4

N2 - Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.

AB - Gastric cancer is rampant in several countries worldwide. Its incidence in the Western hemisphere has been declining for more than 40 years; however, the location of gastric cancer has shifted proximally in the past 15 years. The reason for this shift is unclear. Diffuse histology is also more common now than intestinal type of histology. Advances have been made in staging procedures, such as laparoscopy and endoscopic ultrasonography, and in possible functional imaging techniques. The current TNM classification requires an examination of at least 15 lymph nodes; a DO dissection is unacceptable. Patients with locoregional gastric carcinoma should also be referred to high-volume treatment centers. Combination chemotherapy and radiotherapy in the adjuvant setting for a select group of patients is the new standard in the United States. These guidelines provide a uniform systematic approach to gastric cancer in the United States. Investigation results for new chemotherapeutic agents, including antireceptor agents, vaccines, gene therapy, and antiangiogenic agents, and many future advances in the treatment of gastric carcinoma are anticipated.

KW - Chemoradiation

KW - Chemotherapy

KW - Combined modality therapy

KW - Gastric carcinoma

KW - NCCN Clinical Practice Guidelines

KW - Resection

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=33747132697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747132697&partnerID=8YFLogxK

M3 - Article

C2 - 16569388

AN - SCOPUS:33747132697

VL - 4

SP - 350

EP - 366

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 4

ER -